MBXMBX Biosciences, Inc. Common Stock

MBX Stock Price, Valuation & Chart | MBX Biosciences, Inc. Common Stock

Compare

$60.890-0.04 (-0.07%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology MBX intrinsic value MBX calculated fair value vs price

Overview Financials Dividends Ratios

MBX Historical price chart

MBX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.90B

PE Ratio-25.27

EPS-2.41

Trading Volume352.27K

Today's High/Low62.45/58.81

Dividend Yield0.00

52 Week High/Low72.64/9.63

Shares Outstanding47.60M

MBX Financial Statement

MBX Analyst ratings

MBX Analysis & performance metrics

MBX Company profile

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and…

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the…

MBX Management team

Name

Position

Salomon Azoulay M.D.

Chief Medical Officer

Michelle Graham

Chief Human Resources Officer

Mark Hope

Senior Vice President of Regulatory & Quality

Chatan Charan Ph.D.

Senior Vice President of Pharmaceutical Development & Chemistry, Manufacturing and Controls

Matt Gambino

Vice President of Marketing

Michael A. Dorato DABT, Ph.D.

Senior Vice President of Discovery & Non-Clinical Development

Peter Kent Hawryluk MBACEO

Chief Executive Officer, President & Director

Richard B. Bartram CPACFO

Chief Financial Officer

Name

Position

Salomon Azoulay M.D.

Chief Medical Officer

Michelle Graham

Chief Human Resources Officer

Mark Hope

Senior Vice President of Regulatory & Quality

Chatan Charan Ph.D.

Senior Vice President of Pharmaceutical Development & Chemistry, Manufacturing and Controls

Matt Gambino

Vice President of Marketing

Michael A. Dorato DABT, Ph.D.

Senior Vice President of Discovery & Non-Clinical Development

Peter Kent Hawryluk MBACEO

Chief Executive Officer, President & Director

Richard B. Bartram CPACFO

Chief Financial Officer

Management Team

Salomon Azoulay M.D.

Chief Medical Officer

Michelle Graham

Chief Human Resources Officer

Mark Hope

Senior Vice President of Regulatory & Quality

Chatan Charan Ph.D.

Senior Vice President of Pharmaceutical Development & Chemistry, Manufacturing and Controls

Matt Gambino

Vice President of Marketing

Michael A. Dorato DABT, Ph.D.

Senior Vice President of Discovery & Non-Clinical Development

Peter Kent Hawryluk MBACEO

Chief Executive Officer, President & Director

Richard B. Bartram CPACFO

Chief Financial Officer

Management

Salomon Azoulay M.D.

Chief Medical Officer

Michelle Graham

Chief Human Resources Officer

Mark Hope

Senior Vice President of Regulatory & Quality

Chatan Charan Ph.D.

Senior Vice President of Pharmaceutical Development & Chemistry, Manufacturing and Controls

Matt Gambino

Vice President of Marketing

Michael A. Dorato DABT, Ph.D.

Senior Vice President of Discovery & Non-Clinical Development

Peter Kent Hawryluk MBACEO

Chief Executive Officer, President & Director

Richard B. Bartram CPACFO

Chief Financial Officer

Total 8 executives

MBX Frequently asked questions

What is MBX Biosciences, Inc. Common Stock (MBX) Stock Price?

Current stock price of MBX Biosciences, Inc. Common Stock (MBX) stock is $60.890. The stock price is -0.07% lower in the session. The intraday range can be seen from this page. Volume of MBX Biosciences, Inc. Common Stock (MBX) stock is 352.27K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the MBX Biosciences, Inc. Common Stock (MBX) stock price going up or down today?

The stock price of MBX Biosciences, Inc. Common Stock (MBX) can change with earnings, company news, and overall market sentiment. MBX Biosciences, Inc. Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the MBX Biosciences, Inc. Common Stock stock expensive at its current price?

Whether MBX Biosciences, Inc. Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MBX on this page is -25.27. EPS on this page is -2.41. Compare those figures with peers and growth expectations before deciding if the current MBX Biosciences, Inc. Common Stock price is justified.

How has the stock price of MBX Biosciences, Inc. Common Stock (MBX) performed historically?

Historical performance for MBX Biosciences, Inc. Common Stock (MBX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MBX reacted to past earnings and market events.

Should I buy MBX Biosciences, Inc. Common Stock (MBX) stock, at this price?

Buying MBX Biosciences, Inc. Common Stock (MBX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.